THE ALUMNI MAGAZINE OF A Happy Marriage Fighting the Annual Report BOSTON UNIVERSITY SCHOOL OF LAW of Interests Good Fight of Giving MIT and BU share Four BU Law alumni Building on Excellence: THE Intellectual Property share their passion The Campaign for BU clinics. P.8 for social justice. P.14 School of Law. P.54 RECORD FALL 2016 FALL 2016 INSIDE THE RECORD BU Law The alumni Maureen A. O’Rourke Dean, Professor of Law, receives grant magazine of Michaels Faculty to combat Boston Research Scholar antimicrobial University Oice of Development resistance School of Law & Alumni Relations Lillian Bicchieri, 2 Development Associate Thomas Damiani, Senior Sta A Happy Coordinator Marriage of Terry McManus, 8 Assistant Dean for Interests: Development & BU Law’s IP Alumni Relations Curriculum Oice of Communications & Marketing Ann Comer-Woods, Assistant Dean for Communications & Marketing Lauren Eckenroth, 12 Senior Writer Opportunity in Failure Contributors Rebecca Binder 14 (LAW’06) Patrick L. Kennedy (COM’04) Fighting the Meghan Laska Good Fight: Trevor Persaud (STH’18) Alumni in Indira Priyadarshini Public Service 20 (COM’16) The Right Sara Rimer to Innovate Corinne Steinbrenner (COM’06) Photography Josh Andrus Alex Boerner BU Photography School News John Gillooly & & Updates Professional Event Images, Inc. Max Hirshfeld Tim Llewellyn 22 Chris McIntosh Mark Ostow Photography Melissa Ostrow Class Notes & Jackie Ricciardi Chris Sorensen In Memoriam Michael D. Spencer Dan Watkins Design Ellie Steever, Boston University Creative Services Cover art and Tell us what you illustrations think! Complete our 54 The Red Dress Annual Report Owen Gildersleeves reader survey at of Giving Peter Hoey bit.ly/bulawrecord. 44 Letter from the Dean. Welcome to the 2016 issue of The Record! It has been an exciting year for the law school. Over the summer, the Combating Antibiotic-Resistant Bacte- ria Biopharmaceutical Accelerator (CARB-X) was launched at BU Law under the leadership of Professor of Law and N. Neal Pike Scholar in Health and Disability Law Kevin Outterson. Supported by $350 million in grants from the US government and international agencies, CARB-X provides funding and support to developers of promising new antibiotics, diagnos- tics, and vaccines that tackle the threat of untreatable bacterial infections. Professor Outterson brings a deep understanding of the eco- nomic, environmental, and regulatory policies and laws that are among the factors underlying the global problem of antibiotic resistance. His role as executive director of CARB-X highlights the strength of BU Law’s health law program and the entire University’s commitment to interdisciplinary approaches to solving critical problems. In the following pages, you’ll learn more about this unique collaboration. PHOTO BY DAN AGUIRRE DAN BY PHOTO Energized by the new venture, we have taken this opportunity Rose (’81), Jennifer Serafyn (’01), Ken Monteiro (CAS’84, to showcase our cutting-edge doctrinal and clinical program- LAW’87), and Mona Sahaf (’04)—to discuss their calling to ming. The Entrepreneurship & IP Clinic, launched in fall 2015 work for the public good. in partnership with MIT, has already helped more than 75 student entrepreneurs in the early phases of their start-ups on Alumni and friends like the ones featured in these pages have issues of entity selection and formation, intellectual property, shaped the future of BU Law in many ways. Sharon and Thomas contracts, equity development, data security, finance, and Royall Smith (’70) created a fund to support students providing employment matters. The second half of that partnership, the legal assistance to disadvantaged clients across the US (see page Technology & Cyberlaw Clinic, launched this fall under the 31 to learn more), Barbara Bywater Creed (’69) named a class- direction of Andy Sellars, who joined us from Harvard’s Berk- room in the Redstone Building in honor of the learning that will man Klein Center for Internet & Society. take place there for years to come, and Paula and Robert T. But- ler (’55) endowed a scholarship to ensure the best and brightest In this magazine, you will read about alumni who have been students can attend BU Law. These are just a few of the many motivated to innovate in their own ways—from Anil Aggarwal’s highlights from this year that demonstrate our shared com- (’95) passion for entrepreneurship and drive to push the finan- mitment to the future of the School. Because of gifts like these, cial technology industry forward to Igor Bratnikov’s (’12) leap the Building on Excellence Campaign—which was extended of faith as he chose to invest in his own start-up after graduating last year from an original goal of $80 million to $100 million by from law school. It is that kind of spirit that Michael Fricklas June 2019—continues to gain momentum. See the letter from (’84) and Donna Astion (SAR’82) were inspired to support Richard Godfrey (’79), chair of the School of Law Campaign, on with their pledge of $1 million to BU to endow scholarship and page 56 for more information. research funds at the School of Law and Sargent College. I would like to thank each and every one of you who has made As we celebrate such invention and forward thinking, we BU Law what it is today. I look forward to seeing you in my trav- remember that the drive to innovate doesn’t only strike those els around the country this year, and I encourage you to keep in with entrepreneurship in mind. We caught up with four alumni touch and visit our BU Law complex to understand the impact working for public service and nonprofit organizations—Ken your support has had on the current generation of law students. MAUREEN A. O’ROURKE, DEAN, PROFESSOR OF LAW, MICHAELS FACULTY RESEARCH SCHOLAR THE RECORD Fall 2016 1 COVER STORY CARB X GRANT SUPERBUGS MEET SUPER FOE BY SARA RIMER A NETWORK RALLIES FOR NEW ANTIBIOTICS Kevin Outterson’s first phone call was to John H. Rex, a leader in antibiotic drug development and a colleague from Outterson’s antibiotic-resistance policy work for the European Union. When Outterson, a professor of law and director of BU Law’s health law program, began study- ing the problem of antibiotic- resistant germs a decade ago, few people outside academia seemed interested. Now, however, at the end of February 2016, amid a consensus among international health officials and world lead- ers that the problem required urgent action, the Biomedical Advanced Research and Develop- ment Authority (BARDA) had just announced a $250 million grant opportunity to establish a novel partnership to accelerate the preclinical development of new antibiotics. 2 2 PHOTO BY JACKIE RICCIARDI Outterson wanted to put and the California Life Sciences Insti- together a trans-Atlantic team of tute in San Francisco. leading scientists, biotech innovators, in this ield. and major funders with an unusual Outterson reached out to Deborah He deserves decentralized structure that would Hung, codirector of the Broad Insti- a lot of credit for spur innovation without adding layers tute’s infectious disease program and having the vision of bureaucracy—and apply for the associate professor of microbiology and the courage to grant. and immunobiology at Harvard Medi- undertake this extremely cal School. “He asked me, ‘What is the ambitious project. He was Would Rex join the team? The com- biggest problem that gets in the way working under incredible dead- pleted 50-page application was due in of innovation in antibiotic resistance line pressure and managed to get less than 60 days. and drug discovery being developed the necessary people on board to pull oª a winning proposal in record “When he proposed it, my jaw sort time.” of hit the loor,” says Rex, senior vice president and chief strategy oicer for “Relationships really matter when you AstraZeneca Pharmaceuticals’ Infec- want to build something innovative,” tion Business Unit. “As I listened to Outterson says. He credits the connec- Kevin, I thought it was a brilliant idea.” tions he made during his 2014 sabbati- cal at Chatham House, an independent BARDA was especially interested in policy institute in London, and through applicants who could come in with sig- DRIVE AB®Driving Reinvestment in niicant additional funds. “Wellcome R&D and Responsible Antibiotic Use—a Trust was at the top of our list and public-private consortium funded by John had been working with them the European Union’s Innovative Medi- for several years on drug innovation,” “ Kevin has the best cines Initiative. Outterson says. “I got on a plane to Rolodex of anyone London.” He joined Rex at a meeting “It’s really not about me,” says Outter- at the global foundation’s London in antibiotics.” son, who was a founding member of headquarters. the Centers for Disease Control and — Gloria Waters, Vice President, Associate Provost for Research, Prevention’s Working Group on Antimi- “They had been in the process of a Boston University crobial Resistance in 2011. “It’s about strategic review of how they funded the network of people who understand biomedical R&D,” Outterson says. “Our the complexity of this problem and discussions were amazingly fruitful.” into translational reality?’” recalls have worked together in various proj- Hung. “We had a discussion about how ects over the past decade.” Outterson and Rex left that meeting, you would bridge the gap.” on March 8, 2016, with nothing more “One of the good things about this than a handshake, but by April 15, Hung’s answer to the question was [CARB X],” says Rex, “is that the Wellcome Trust had not only signed a the Broad’s new interdisciplinary executive director—Kevin—is not in commitment letter, they had recruited Collaborative Hub for Early Antibiotic the game the way the rest of us are.